Spotlight on Influenza - Separating Fact from Fiction in the Battle Against Influenza

In particular, the report looks at pharma's pipeline prospects in the influenza field and discusses potential new treatments and vaccines in development, while simultaneously assessing their potential marketing position and value. As well as probing the industry's ongoing investigative efforts, the report also broadly analyses and outlines the current markets, including available therapeutic products.

Looking to the future, the ramifications of the pandemic threat and its potential long-term repercussions will be reviewed from a global healthcare and commercial market perspective. The report also covers deal making and licensing opportunities, which have stemmed from the flu threat, providing an analysis of the companies and therapies involved. Background on the history of the flu, details of the different strains and viral targets for therapeutic intervention will be described in detail as a key contextualising element of this report.

This topical report provides readers with insightful competitor intelligence and extended market analysis compiled from PharmaDeals®. You can therefore be sure that you are accessing the most up-to-date and timely information available.

Published 2006
Table of Contents
Price: $995.00 / GBP497.50